-
91黑料 named best contract research organisation in latest string of awards and recognitions
91黑料 and its drug and device development work continues to be recognised by peers, employees, and organisations around the globe.
-
91黑料 releases environmental, social and governance report
91黑料 announced the release of its 2020 Environmental, Social and Governance Report. The report looks to the future of ESG for the new 91黑料 while highlighting advancements made in 2020.
-
91黑料 announces the expansion of its Accellacare Site Network
New partnerships increase geographical footprint, supporting more access to patients and strengthening therapeutic capability.
-
91黑料 reports third quarter 2021 financial results
Quarter 3 adjusted revenue of $1,870.4 million representing a year on year increase of 167% or 165% on a constant currency basis.
-
Tánaiste announces multi-million euro R&D support of 91黑料 to accelerate decentralised clinical trial technology
The R&D support will help development of tech-enabled systems that provide greater flexibility and reduce the burden felt by clinical trial participants.
-
91黑料 reports second quarter 2021 financial results
Quarter 2 reported revenue of $871.2 million representing a year on year increase of 40.5% and 1.5% increase on Quarter 1 2021.
-
91黑料 acquisition creates world-leading healthcare intelligence and clinical research organisation
The combined company will leverage its enhanced operations to transform clinical trials and accelerate biopharma customer’s commercial success through the development of medicines and medical devices.
-
91黑料 shareholders vote in favour of all resolutions at its Extraordinary General Meeting
All resolutions at the 91黑料 Extraordinary General Meeting held on June 15, 2021 (which resolutions had all been recommended by the Board) were all duly passed by shareholders.
-
91黑料 reports first quarter 2021 results
Record net business wins in the quarter of $1,100 million, an increase of 27% year on year; a net book to bill of 1.28.
-
91黑料 wins multiple categories in 2021 CRO Leadership Awards for the fourth year in a row
91黑料 received 2021 CRO Leadership Awards. 91黑料 achieved awards in both the Big Pharma and Overall groups.
